We are live on ! Find out more
SHI

SV Health Investors Portfolio holdings

AUM $32.3M
1-Year Est. Return 20.15%
This Fund
S&P 500
This Quarter Est. Return
-10.09%
1 Year Est. Return
-20.15%
3 Year Est. Return
+97.4%
5 Year Est. Return
+328.26%
10 Year Est. Return
–
AUM
$142M
AUM Growth
-$6.61M
Cap. Flow
+$15.9M
Cap. Flow %
11.17%
Top 10 Hldgs %
100%
Holding
10
New
1
Increased
–
Reduced
2
Closed
–

Top Buys

Rank Stock Value
1
MSON
Misonix Inc
MSON
+$36.7M

Top Sells

Rank Stock Value
1
DCPH
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
+$11.1M
2
TECX
Tectonic Therapeutic
TECX
+$9.69M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MSON
1
DELISTED
Misonix Inc
MSON
$34.1M 23.94%
+1,695,969
New +$36.7M
BCYC
2
Bicycle Therapeutics
BCYC
$303M
$21.8M 15.32%
1,915,274
– –
TECX
3
Tectonic Therapeutic
TECX
$717M
$20M 14.06%
118,100
-42,792
-27% -$9.69M
KALV
4
DELISTED
KalVista Pharmaceuticals
KALV
$19.9M 14.01%
1,719,576
– –
DCPH
5
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$18.4M 12.93%
542,143
-376,194
-41% -$11.1M
STRO icon
6
Sutro Biopharma
STRO
$353M
$16.6M 11.65%
182,454
– –
ASXC
7
DELISTED
Asensus Surgical, Inc.
ASXC
$4.11M 2.89%
510,141
– –
XFOR icon
8
X4 Pharmaceuticals
XFOR
$419M
$3.96M 2.78%
10,383
– –
OCUL icon
9
Ocular Therapeutix
OCUL
$2.38B
$1.91M 1.34%
628,236
– –
ATXS
10
DELISTED
Astria Therapeutics
ATXS
$1.54M 1.08%
47,628
– –

Similar funds

SAM
Serengeti Asset Management New York $31.8M AUM 23.16% 1-Year Est. Return
FCOMV
Foresite Capital Opportunity Management V Larkspur, California $33.3M AUM 47.04% 1-Year Est. Return
LUGPSI
Lightspeed Ultimate General Partner Select III Menlo Park, California $31M AUM 76.89% 1-Year Est. Return
VCA
VIEX Capital Advisors Sunny Isles Beach, Florida $30.9M AUM 55.48% 1-Year Est. Return
PGM
Parian Global Management Pound Ridge, New York $30.8M AUM 51.25% 1-Year Est. Return
ACM
Afton Capital Management Charlotte, North Carolina $30.6M AUM 56.8% 1-Year Est. Return
KCM
Kingstown Capital Management New York $30.4M AUM 3.71% 1-Year Est. Return
KXA
KPCB XV Associates Menlo Park, California $35.8M AUM 57.59% 1-Year Est. Return

SV Health Investors's Q3 2019 Portfolio in Review

As of Q3 2019, SV Health Investors held 10 positions worth $142M, down 4.4% from $149M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

SV Health Investors deployed $15.9M of net new capital in Q3 2019, opening 1 new position. Its largest new stake was Misonix Inc: 1,695,969 shares worth $34.1M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

On the sell side, the largest reduction was Deciphera Pharmaceuticals, Inc. Common Stock, an estimated $11.1M trimmed.

  • SV Health Investors's largest Q3 2019 buy was Misonix Inc: 1,695,969 shares worth $34.1M.
  • SV Health Investors's biggest Q3 2019 reduction was Deciphera Pharmaceuticals, Inc. Common Stock, cutting an estimated $11.1M.
  • SV Health Investors's ten largest holdings make up 100% of its $142M portfolio in Q3 2019.
  • SV Health Investors opened 1 new position and closed 0 in Q3 2019.
  • SV Health Investors's portfolio value fell 4.4% quarter-over-quarter to $142M.

Based on SV Health Investors's 13F filing for Q3 2019, filed 14 Nov 2019.